Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis

  • Elizabeth Lee Carpenter
  • , Spencer Van Decar
  • , Alexandra M. Adams
  • , Anne E. O'Shea
  • , Patrick McCarthy
  • , Robert Connor Chick
  • , Guy Travis Clifton
  • , Timothy Vreeland
  • , Franklin A. Valdera
  • , Ankur Tiwari
  • , Diane Hale
  • , Phillip Kemp Bohan
  • , Annelies Hickerson
  • , Todd Smolinsky
  • , Katryna Thomas
  • , Jessica Cindass
  • , John Hyngstrom
  • , Adam C. Berger
  • , James Jakub
  • , Jeffrey J. Sussman
  • Montaser F. Shaheen, Xianzhong Yu, Thomas E. Wagner, Mark Faries, George E. Peoples

Producción científica: Articlerevisión exhaustiva

Huella

Profundice en los temas de investigación de 'Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis'. En conjunto forman una huella única.
Clasificar por

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology